- Home
- RPTX vs LFCR Comparison
RPTX vs LFCR Comparison
Compare RPTX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- LFCR
- Stock Information
- Founded
- RPTX 2016
- LFCR 1986
- Country
- RPTX Canada
- LFCR United States
- Employees
- RPTX N/A
- LFCR N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- LFCR Health Care
- Exchange
- RPTX Nasdaq
- LFCR Nasdaq
- Market Cap
- RPTX 155.4M
- LFCR 164.3M
- IPO Year
- RPTX 2020
- LFCR N/A
- Fundamental
- Price
- RPTX $3.59
- LFCR $6.74
- Analyst Decision
- RPTX Strong Buy
- LFCR Buy
- Analyst Count
- RPTX 1
- LFCR 2
- Target Price
- RPTX $10.00
- LFCR $8.00
- AVG Volume (30 Days)
- RPTX 71.8K
- LFCR 137.8K
- Earning Date
- RPTX 11-07-2024
- LFCR 10-04-2024
- Dividend Yield
- RPTX N/A
- LFCR N/A
- EPS Growth
- RPTX N/A
- LFCR N/A
- EPS
- RPTX N/A
- LFCR 0.17
- Revenue
- RPTX $68,683,000.00
- LFCR $128,443,999.00
- Revenue This Year
- RPTX $16.85
- LFCR $2.23
- Revenue Next Year
- RPTX N/A
- LFCR $8.40
- P/E Ratio
- RPTX N/A
- LFCR $40.49
- Revenue Growth
- RPTX N/A
- LFCR 23.42
- 52 Week Low
- RPTX $2.71
- LFCR $3.68
- 52 Week High
- RPTX $8.49
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- RPTX 53.00
- LFCR 75.89
- Support Level
- RPTX $3.37
- LFCR $5.56
- Resistance Level
- RPTX $4.05
- LFCR $5.98
- Average True Range (ATR)
- RPTX 0.26
- LFCR 0.24
- MACD
- RPTX 0.00
- LFCR 0.12
- Stochastic Oscillator
- RPTX 40.65
- LFCR 93.49
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.